1 / 82

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD). A process characterized by the presence of chronic bronchitis, emphysema, or both, leading to the development of airway obstruction. What is COPD?. What is COPD?. COPD is a serious lung disease that makes it hard to breathe.

sancho
Télécharger la présentation

Chronic Obstructive Pulmonary Disease (COPD)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic Obstructive Pulmonary Disease (COPD) • A process characterized by the presence of chronic bronchitis, emphysema, or both, leading to the development of airway obstruction

  2. What is COPD?

  3. What is COPD? • COPD is a serious lung disease that makes it hard to breathe. • airways are partly blocked, which makes it hard to get air in and out • Emphysema- damage to air sacs in lungs • Chronic bronchitis- swelling of air passages that lead to lungs

  4. Statistics • 3rd leading cause of death in the U.S. • Over 12 million are currently diagnosed and an estimated additional 12 million have it but haven’t been diagnosed

  5. 6

  6. 7

  7. 8

  8. Etiology I am doing it, my etiology

  9. COPD • Causes • Smoking (90%) • Environmental factors • Air pollution, confined kitchen areas • Genetics: α1-antitrypsin • Produced in liver • Protects lung against elastase • Elastase breaks down elastin • No elastin= no recoil • Deficiency  liver and lung failure • Less than 1% of COPD patients • Without smoking

  10. Emphysema • Imbalance of antiproteases & proteases Normal Cigarette smoke recruit neutrophils Cigarette smoke oxidation α1-antitrypsin deficiency Increased proteases

  11. Emphysema • α1-antitrypsin deficiency & increased proteases • Collagen and elastin destruction • Flabby lung • ↓ recoil • Abnormal enlargement & destruction of alveoli • ↓ SA

  12. Chronic Bronchitis • Cigarette smoke irritants inflammation of airway • Hyperplasia and hypertrophy of mucus glands • Hypertrophy of goblet cells increased mucus • Smaller airway + more mucus = mucus plug

  13. Case Study • SB • Age 62 • Smoking history: 1 pack/day for 46 years • Quit 1 year ago

  14. Pathophysiology

  15. Physiology of Pulmonary System • Functions • Acid-Base Balance • Synthesize arachidonic acid • Prostaglandins, Leukotrienes • ACE converts Ang. I to Ang. II • Gas exchange • Surfactant • Immune defense

  16. Gas Exchange

  17. Basic Pathophysiology • Emphysema • Permanent enlargement of acini with alveolar destruction • Closure of small airways • Primary: Alpha-1 Antitrypsin deficiency (inherited) • Secondary: Inability to inhibit proteolytic enzymes (smoking, etc.) • Chronic Bronchitis • Hypersecretion of thick immobile mucus and productive cough • Mucus obstruction of bronchioles • Continuous bronchial inflammation * Common for patients to display both types

  18. Inflammation of COPD

  19. Emphysema • Pathophysiology • Smoke irritants cause inflammation of the epithelial • Protease activity increased by cytokines • Elastase, Cathepsin, Metalloprotease. • Imbalance of proteases and anti-proteases cause a breakdown on elastin in alveolar septa • Reduced elastic recoil and expiration • Eliminated portions of pulmonary capillary bed • Diminished airway caliber • Air-trapping (causing barrel chest) • Bronchoconstriction (caused by persistent inflammation)

  20. Emphysema

  21. Chronic Bronchitis • Pathophysiology • Smoking/irritants stimulate mucus production • Ciliary function impaired= reduced mucus clearance • Bacterial growth and inflammation= more mucus production • Bronchial/Bronchiolar walls thicken • Persistence involves bronchospasms and narrowing of the airways • Obstuction (Mucus + wall thickening + lumen narrowing) • Airway collapse in expiration

  22. Chronic Bronchitis

  23. 25

  24. Effects on Energy • Affect on energy metabolism • Protein degradation - Cachexia

  25. Acute Exacerbations • Accelerated loss of lung function and poor quality of life • Severe Pulmonary Hypertension • PA:A ratio >1 =pulmonary artery enlargement • Other effects: • Increase in dyspnea, hypercapnia, cough, and/or sputum production • New strains of bacteria or viruses; environmental factors • Ischemia, Heart Failure, Thromboembolism

  26. Cor Pulmonale • Late stages • From chronic PAH: • Low PAO2 /Hypoxia causes pulmonary vasoconstriction • Can be reversed if PACO2 is cleared but… • Resistance to PA blood flow • Increased workload of RV • Peripheral edema noted

  27. Signs & Symptoms

  28. Emphysema • No mucus or cough • Barrel chest • ↓ lung plasticity & hyperinflation • Pressure around the lung greater • than pressure in the lung • Lung collapse • Trapped air • Expand anteroposteriorly

  29. Emphysema • Breathing Habits • Lean forward • Stabilizes chest • Allows max expansion • Accessory muscles • Pursed lips • More air out before lung collapse

  30. Emphysema • Older (>50) • Underweight, cachectic • Late cor pulmonale • Decreased DLCO • ↓ alveolar SA • “Pink puffers”

  31. Chronic Bronchitis • Hypersecretion of mucus and chronic productive cough for 3 months for 2 consecutive years • Shorteness of breath, even at rest • Wheezing • Normal weight but often overweight

  32. Chronic Bronchitis • V/Q Mismatch • V= Ventilation; air that reaches alveoli • Q=Perfusion; blood that reaches alveoli • Hypoxemia • Cyanosis around lips • “Blue bloaters” • Stimulates renal secretion of erythropoietin • High hematocrit • Vasoconstriction hypertension early cor pulmonale

  33. Case Study “I am gasping for air” “I am coughing up a lot of phlegm” “I am always short of breath” No cyanosis or clubbing Wheezing Uses accessory muscles at rest

  34. Diagnosis

  35. Spirometry • Pt inhales & then exhales as • much and as fast as possible • Measures • FVC • FEV1 • FEV1/FVC

  36. Spirometry

  37. Spirometry • Post-bronchodilator FEV1 / FVC <.7 confirms airflow limitation that is not fully reversible

  38. Diffusion of Lung Capacity • DLCO • Patient inhales small amount of CO • Compare the amount exhaled by amount inhaled • Determines amount absorbed • ↓ indicative of emphysema but not chronic bronchitis

  39. Prognosis

  40. Prognosis • Not curable • Slow damage • Prevent exacerbation • acute change in symptoms to needing a change in therapy • dyspnoea • cough and/or sputum

  41. 43

  42. Quality of Life • ADLs • http://www.youtube.com/watch?v=G3vmSDXHwMI

  43. Case Study “I’m hardly able to do anything for myself…my husband had to help me out of the shower this morning.”

  44. Treatment

  45. Treatment • No cure • Quite smoking • Walk to strengthen muscles needed for breathing • Avoid cold air • Avoid smoke, make sure no one smokes in your home • Reduce air pollution by getting rid of fireplace smoke and other irritants

  46. 48

  47. Medications: Bronchodilators • Inhalers (Bronchodilators) work to relax the muscles around the airways, to help open them and make it easier to breathe. • Some Inhalers include: ipratropium (Atrovent), tiotropium (Spiriva), salmeterol (Serevent), formoterol (Foradil), or albuterol

  48. Medications: Inhaled Steroids • Reduce lung inflammation • Most commonly used inhaled corticosteroids: fluticasone propionate, budesonide, and beclometasone dipropionate

More Related